SCHEMBL21937752

SCHEMBL21937752

Sc1cccc2c1CCCC21CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 15/20 0.35
EBP Q15125 1/20 0.35
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
DRD2 P14416 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR2B P41595 1/20 0.33
MTOR P42345 1/20 0.33
MEN1 O00255 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258172 0.88 KDM1A (0.33) SIGMAR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL24258173 0.77 KDM1A (0.35) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL21936942 0.77 PDE7A (0.36) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL21937753 0.77 SIGMAR1 (0.33) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL21936824 0.77 PDK2 (0.36) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL24258225 0.73 KDM1A (0.35) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL17014495 0.73 ALDH1A1 (0.48) SIGMAR1CYP3A4DRD2
SCHEMBL21937081 0.73 SIGMAR1 (0.33) SIGMAR1EBPTP53CYP1A2CYP3A4
SCHEMBL28795508 0.72 PDE7A (0.41) SIGMAR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL21845443 0.72 GFER (0.41) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020072835-A1 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2020-04-09 WO disclosed